Identification of the critical regions in the hepatitis B virus preS required for its stability

Journal of Peptide Science

Volumn 14, Issue 3, 2008, Pages 307-312

  Lian, Min ^a   Zhou, Xu ^a   Chen, Bin ^a   Li, Chan ^a   Gu, Xiaocheng ^a   Luo, Ming ^a,b   Zheng, Xiaofeng ^a  

^a PEKING UNIVERSITY   (China)

^b University of Alabama at Birmingham   (United States)

Author keywords

Binding affinity; Critical region; PreS; Proper folding; Stability

Indexed keywords

AMINO ACID; HEPATITIS B VIRUS PRES PROTEIN; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ESCHERICHIA COLI; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY;

AMINO ACID MOTIFS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; PROTEIN PRECURSORS; VIRAL ENVELOPE PROTEINS;

ESCHERICHIA COLI; HEPATITIS B VIRUS;

EID: 40749161911     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.929     Document Type: Article

References (28)

1. Liaw YF, Tai DI, Chu CM, Lin DY, Sheen IS, Chen TJ, Pao CC. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study. Gastroenterology 1986; 90: 263-267.
2. Kane M. Global programme for control of hepatitis B infection. Vaccine 1995; 13(Suppl 1): S47-S49.
3. Tiollais P, Buendia MA. Hepatitis B virus. Sci. Am. 1991; 264: 116-123.
4. Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature 1985; 317: 489-495.
5. Courouce-Pauty AM, Plancon A, Soulier JP. Distribution of HBsAg subtypes in the world. Vax. Sang. 1983; 44: 197-211.
6. Akuta N, Kumada H. Influence of hepatitis B virus genotypes on the response to antiviral therapies. J. Antimicrob. Chemother. 2005; 55: 139-142.
7. Neurath AR, Kent SB, Strick N, Parker K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 1986; 46: 429-436.
8. Petit MA, Dubanchet S, Capel F, Voet P, Dauguet C, Hauser P. HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1 (21-47). Virology 1991; 180: 483-491.
9. Pontisso P, Ruvoletto MG, Tiribelli C. Gerlich WH, Ruol A, Alberti A. The preS1 domain of hepatitis B virus and IgA cross-react in their binding to the hepatocyte surface. J. Gen. Virol. 1992; 73(Pt 8): 2041-2045.
10. Glebe D, Urban S, Knoop EV, Cag N, Krass P, Grun S, Bulavaite A, Sasnauskas K, Gerlich WH. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. Gastroenterology 2005; 129: 234-245.
11. Barrera A, Guerra B, Notvall L, Lanford RE. Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition. J. Virol. 2005; 79: 9786-9798.
12. Barrera A, Guerra B, Lee H, Lanford RE. Analysis of host range phenotypes of primate hepadnaviruses by in vitro infections of hepatitis D virus pseudotypes. J. Virol. 2004; 78: 5233-5243.
13. Stoeckl L, Funk A, Kopitzki A, Brandenburg B, Oess S, Will H, Sirma H, Hildt E. Identification of a structural motif crucial for infectivity of hepatitis B viruses. Proc. Natl. Acad. Sci. U.S.A. 2006; 103: 6730-6734.
14. Oess S, Hildt E. Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens. Gene Ther. 2000; 7: 750-758.
15. Le Seyec J, Chouteau P, Cannie I, Gugen-Guillouzo C, Gripon P. Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity. J. Virol. 1998; 72: 5573-5578.
16. Andrade MA, Chacon P, Merelo JJ, Moran F. Evaluation of secondary structure of proteins from UV circular dichroism spectra using an unsupervised learning neural network. Protein Eng. 1993; 6: 383-390.
17. Johnson WC Jr. Protein secondary structure and circular dichroism: a practical guide. Proteins 1990; 7: 205-214.
18. Chang J, Kim DH, Lee SW, Choi KY, Sung YC. Transactivation ability of p53 transcriptional activation domain is directly related to the binding affinity to TATA-binding protein. J. Biol. Chem. 1995: 270:25014-25019.
19. Gripon P, Le Seyec J, Rumin S, Guguen-Guillouzo C. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology 1995; 213: 292-299.
20. Bruss V, Hagelstein J, Gerhardt E, Galle PR. Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity. Virology 1996; 218: 396-399.
21. Glebe D, Urban S. Viral and cellular determinants involved in hepadnaviral entry. World J. Gastroenterol. 2007; 13: 22-38.
22. Deng Q, Kong YY, Xie YH, Wang Y. Expression and purification of the complete PreS region of hepatitis B Virus. World J. Gastroenterol. 2005; 11: 3060-3064.
23. De Meyer S, Gong ZJ, Suwandhi W, van Pelt J, Soumillion A, Yap SH. Organ and species specificity of hepatitis B virus (HBV) infection: a review of literature with a special reference to preferential attachment of HBV to human hepatocytes. J. Virol. Hepat. 1997; 4: 145-153.
24. Cooper A, Paran N, Shaul Y. The earliest steps in hepatitis B virus infection. Biochim. Biophys. Acta. 2003; 1614: 89-96.
25. De Falco S, Ruvoletto MG, Verdoliva A, Ruvo M, Raucci A. Marino M, Senatore S, Cassani G, Alberti A, Pontisso P, Fassina G. Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells. J. Biol. Chem. 2001; 276: 36613-36623.
26. Urban S, Gripon P. Inhibition of duck hepatitis B virus infection by a myristoylated pre-S peptide of the large viral surface protein. J. Virol. 2002; 76: 1986-1990.
27. Meisel H, Sominskaya I, Pumpens P, Pushko P, Borisova G, Deepen R, Lu X, Spiller GH, Kruger DH, Grens E, Gerlich WH. Fine mapping and functional characterization of two immuno-dominant regions from the preS2 sequence of hepatitis B virus. Intervirology 1994; 37: 330-339.
28. Nunez E, Wei X, Delgado C, Rodriguez-Crespo I, Yelamos B, Gomez-Gutierrez J, Peterson DL, Gavilanes F. Cloning, expression, and purification of histidine-tagged preS domains of hepatitis B virus. Protein Expr. Purif. 2001; 21: 183-191.